Teladoc Health Inc (NYSE:TDOC)’s traded shares stood at 1.07 million during the latest session, with the company’s beta value hitting 0.98. At the last check today, the stock’s price was $11.08, to imply an increase of 2.71% or $0.29 in intraday trading. The TDOC share’s 52-week high remains $22.54, putting it -103.43% down since that peak but still an impressive 38.99% since price per share fell to its 52-week low of $6.76. The company has a valuation of $1.91B, with an average of 6.89 million shares in intraday trading volume over the past 10 days and average of 5.70 million shares over the past 3 months.
Analysts have given a consensus recommendation of Hold for Teladoc Health Inc (TDOC), translating to a mean rating of 2.57. Of 19 analyst(s) looking at the stock, 0 analyst(s) give TDOC a Sell rating. 0 of those analysts rate the stock as Overweight while 10 advise Hold as 9 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.29.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Teladoc Health Inc (NYSE:TDOC) trade information
After registering a 2.71% upside in the latest session, Teladoc Health Inc (TDOC) has traded red over the past five days. The 5-day price performance for the stock is -7.49%, and 17.40% over 30 days. With these gigs, the year-to-date price performance is -48.57%. Short interest in Teladoc Health Inc (NYSE:TDOC) saw shorts transact 25.69 million shares and set a 4.26 days time to cover.
The extremes give us $9 and $20 for target low and target high price respectively. As such, TDOC has been trading -80.51% off suggested target high and 18.77% from its likely low.
Teladoc Health Inc (TDOC) estimates and forecasts
Looking at statistics comparing Teladoc Health Inc share performance against respective industry, we note that the company has underperformed competitors. Teladoc Health Inc (TDOC) shares are 4.16% up over the last 6 months, with its year-to-date growth rate lower than industry average at -332.84% against 7.70%. The rating firms project that company’s revenue will shrink -1.30% compared to the previous financial year.
Revenue forecast for the current quarter as set by 23 analysts is 639.92M. Meanwhile, for the current quarter, a total of 17 analyst(s) estimate revenue growth to 632.09M.Earnings reports from the last fiscal year show that sales brought in 660.53M and 646.13M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -3.12% before dropping -2.17% in the following quarter.
TDOC Dividends
Teladoc Health Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Teladoc Health Inc (NYSE:TDOC)’s Major holders
Teladoc Health Inc insiders hold 0.81% of total outstanding shares, with institutional holders owning 77.22% of the shares at 77.85% float percentage. In total, 77.22% institutions holds shares in the company, led by BLACKROCK INC. As of 2024-06-30, the company held over 21.61 million shares (or 12.8843% of shares), all amounting to roughly $211.35 million.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 17.22 million shares, or about 10.2643% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $168.38 million.
